Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog
Ros Cheetham

Ros Cheetham

Expert in global clinical development, global clinical operations including partnership and alliance strategy.

Connect with Ros Cheetham on LinkedIn
Website:

About the author:

Ros is a pharmaceutical development consultant providing expertise in global drug development, global clinical operations solutions and partnership and alliance strategy, with over 30 years in the pharmaceutical industry. Her broad industry experience encompasses several Vice President positions including Global Clinical Operations at Allergan and as Medicines Development Leader at GlaxoSmithKline in Neurosciences and then Rare Diseases. Her experience has included leading product development teams through to successful filing and commercialization of new drugs as well as having implemented innovative global operational solutions that provided cost savings with timely execution and high quality.


Posts by Ros Cheetham

Innovative Repurposing: New Drugs From Old

Posted on May 26th, 2016 in Chemistry

Re-purposing of drugs is fraught with challenges, but can they be overcome so that patients benefit? The term re-purposing is often associated with the idea of saving a few bucks by taking something old and turning it into something useful (like transforming an empty wine bottle into a bird feeder). In the pharmaceutical world, though Continue reading “Innovative Repurposing: New Drugs From Old” »

Molecular Relatives: Prodrugs

Posted on May 19th, 2016 in Pharma R&D

I’m an avid sailor, and on our boat we have an amazing device known as a water-maker. It is probably one of the most useful pieces of equipment on board for long cruises, as it takes in sea water, and, through a process of reverse osmosis, provides potable drinking water. Continue reading “Molecular Relatives: Prodrugs” »

Trail-blazing innovation – Seeking the new blockbuster

Posted on April 11th, 2016 in Pharma R&D

The Holy Grail of the 21st century, at least for pharmaceutical companies, is the one blockbuster drug that will reap rewards of $1Billion+ in peak sales. Continue reading “Trail-blazing innovation – Seeking the new blockbuster” »